Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters.
- DOI
- 10.1021/jacs.3c07010
- Published
- 2023 Oct 11
- Container
- Journal of the American Chemical Society
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/jacs.3c07010,
title = {Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters.},
author = {Casamajo AR and Yu Y and Schnepel C and Morrill C and Barker R and Levy CW and Finnigan J and Spelling V and Westerlund K and Petchey M and Sheppard RJ and Lewis RJ and Falcioni F and Hayes MA and Turner NJ},
year = {2023},
journal = {Journal of the American Chemical Society},
doi = {10.1021/jacs.3c07010},
url = {https://doi.org/10.1021/jacs.3c07010}
}RIS
TY - JOUR TI - Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters. AU - Casamajo AR AU - Yu Y AU - Schnepel C AU - Morrill C AU - Barker R AU - Levy CW AU - Finnigan J AU - Spelling V AU - Westerlund K AU - Petchey M AU - Sheppard RJ AU - Lewis RJ AU - Falcioni F AU - Hayes MA AU - Turner NJ PY - 2023 JO - Journal of the American Chemical Society DO - 10.1021/jacs.3c07010 UR - https://doi.org/10.1021/jacs.3c07010 ER -
APA
AR, C., Y, Y., C, S., C, M., R, B., CW, L., J, F., V, S., K, W., M, P., RJ, S., RJ, L., F, F., MA, H., & NJ, T. (2023). Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters.. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c07010
Source records
- pubmed · retrieved 2026-09-26T21:20:16.489Z